From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) ranks the most common primary liver malignancy and the third leading cause of tumor-related mortality worldwide. Unfortunately, despite advances in HCC treatment, less than 40% of HCC patients are eligible for potentially curative therapies. Recently, cancer immunother...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yaojie, Liu, Shanshan, Zeng, Shan, Shen, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734524/
https://www.ncbi.nlm.nih.gov/pubmed/31500650
http://dx.doi.org/10.1186/s13046-019-1396-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734524/
https://www.ncbi.nlm.nih.gov/pubmed/31500650
http://dx.doi.org/10.1186/s13046-019-1396-4

Ejemplares similares